The effect of exercise on resting concentrations of peripheral brain-derived neurotrophic factor (BDNF) in major depressive disorder: A meta-analysis

Journal of Psychiatric Research

Volumn 105, Issue , 2018, Pages 123-131

  Dinoff, Adam ^a   Herrmann, Nathan ^a,b   Swardfager, Walter ^b   Gallagher, Damien ^a,b   Lanctôt, Krista L ^a,b  

^a Sunnybrook Health Sciences Centre   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

BDNF; Brain derived neurotrophic factor; Depression; Exercise; Major depressive disorder; Meta analysis

Indexed keywords

ANTIDEPRESSANT AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; BDNF PROTEIN, HUMAN;

AEROBIC EXERCISE; BIBLIOGRAPHIC DATABASE; BODY MASS; DATA BASE; ELECTROCONVULSIVE THERAPY; EXERCISE; EXERCISE INTENSITY; HOSPITAL PATIENT; HUMAN; MAJOR DEPRESSION; MENTAL PATIENT; META ANALYSIS; NERVOUS SYSTEM DEVELOPMENT; OUTPATIENT; OXYGEN CONSUMPTION; PRIORITY JOURNAL; RESISTANCE TRAINING; REVIEW; RISK FACTOR; SYSTEMATIC REVIEW; TREATMENT DURATION; ADULT; BLOOD; FEMALE; KINESIOTHERAPY; MALE; PHYSIOLOGY; PROCEDURES;

ADULT; BRAIN-DERIVED NEUROTROPHIC FACTOR; DEPRESSIVE DISORDER, MAJOR; EXERCISE; EXERCISE THERAPY; FEMALE; HUMANS; MALE;

EID: 85053332726     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2018.08.021     Document Type: Review

References (79)

1. NationalCouncilOnStrength&FitnessNationalCouncilOnStrength&Fitness, Relationship between Percent HR Max and Percent VO2 Max.
2. Acheson, A., Conover, J.C., Fandl, J.P., DeChiara, T.M., Russell, M., Thadani, A., Squinto, S.P., Yancopoulos, G.D., Lindsay, R.M., A BDNF autocrine loop in adult sensory neurons prevents cell death. Nature 374:6521 (1995), 450–453.
3. Ambrogini, P., Lattanzi, D., Ciuffoli, S., Betti, M., Fanelli, M., Cuppini, R., Physical exercise and environment exploration affect synaptogenesis in adult-generated neurons in the rat dentate gyrus: possible role of BDNF. Brain Res. 1534 (2013), 1–12.
4. Angelucci, F., Aloe, L., Vasquez, P.J., Mathe, A.A., Mapping the differences in the brain concentration of brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) in an animal model of depression. Neuroreport 11:6 (2000), 1369–1373.
5. Balu, D.T., Hoshaw, B.A., Malberg, J.E., Rosenzweig-Lipson, S., Schechter, L.E., Lucki, I., Differential regulation of central BDNF protein levels by antidepressant and non-antidepressant drug treatments. Brain Res. 1211 (2008), 37–43.
6. Bjornebekk, A., Mathe, A.A., Brene, S., The antidepressant effect of running is associated with increased hippocampal cell proliferation. Int. J. Neuropsychopharmacol. 8:3 (2005), 357–368.
7. Bjornebekk, A., Mathe, A.A., Brene, S., Running has differential effects on NPY, opiates, and cell proliferation in an animal model of depression and controls. Neuropsychopharmacology 31:2 (2006), 256–264.
8. Bocchio-Chiavetto, L., Bagnardi, V., Zanardini, R., Molteni, R., Nielsen, M.G., Placentino, A., Giovannini, C., Rillosi, L., Ventriglia, M., Riva, M.A., Gennarelli, M., Serum and plasma BDNF levels in major depression: a replication study and meta-analyses. World J. Biol. Psychiatr. 11:6 (2010), 763–773.
9. Brunoni, A.R., Lopes, M., Fregni, F., A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression. Int. J. Neuropsychopharmacol. 11:8 (2008), 1169–1180.
10. Chen, B., Dowlatshahi, D., MacQueen, G.M., Wang, J.F., Young, L.T., Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biol. Psychiatr. 50:4 (2001), 260–265.
11. Cooney, G., Dwan, K., Mead, G., Exercise for depression. J. Am. Med. Assoc. 311:23 (2014), 2432–2433.
12. Coppell, A.L., Pei, Q., Zetterstrom, T.S., Bi-phasic change in BDNF gene expression following antidepressant drug treatment. Neuropharmacology 44:7 (2003), 903–910.
13. Cuijpers, P., Smit, F., Excess mortality in depression: a meta-analysis of community studies. J. Affect. Disord. 72:3 (2002), 227–236.
14. Cuijpers, P., Vogelzangs, N., Twisk, J., Kleiboer, A., Li, J., Penninx, B.W., Comprehensive meta-analysis of excess mortality in depression in the general community versus patients with specific illnesses. Am. J. Psychiatr. 171:4 (2014), 453–462.
15. De Foubert, G., Carney, S.L., Robinson, C.S., Destexhe, E.J., Tomlinson, R., Hicks, C.A., Murray, T.K., Gaillard, J.P., Deville, C., Xhenseval, V., Thomas, C.E., O'Neill, M.J., Zetterstrom, T.S., Fluoxetine-induced change in rat brain expression of brain-derived neurotrophic factor varies depending on length of treatment. Neuroscience 128:3 (2004), 597–604.
16. Dey, S., Singh, R.H., Dey, P.K., Exercise training: significance of regional alterations in serotonin metabolism of rat brain in relation to antidepressant effect of exercise. Physiol. Behav. 52:6 (1992), 1095–1099.
17. Dinoff, A., Herrmann, N., Swardfager, W., Liu, C.S., Sherman, C., Chan, S., Lanctot, K.L., The effect of exercise training on resting concentrations of peripheral brain-derived neurotrophic factor (BDNF): a meta-analysis. PLoS One, 11(9), 2016, e0163037.
18. Dinoff, A., Herrmann, N., Swardfager, W., Lanctot, K.L., The effect of acute exercise on blood concentrations of brain-derived neurotrophic factor in healthy adults: a meta-analysis. Eur. J. Neurosci. 46:1 (2017), 1635–1646.
19. Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E.K., Lanctot, K.L., A meta-analysis of cytokines in major depression. Biol. Psychiatr. 67:5 (2010), 446–457.
20. Dunn, A.L., Trivedi, M.H., Kampert, J.B., Clark, C.G., Chambliss, H.O., Exercise treatment for depression: efficacy and dose response. Am. J. Prev. Med. 28:1 (2005), 1–8.
21. Dwivedi, Y., Rizavi, H.S., Conley, R.R., Roberts, R.C., Tamminga, C.A., Pandey, G.N., Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects. Arch. Gen. Psychiatr. 60:8 (2003), 804–815.
22. Egan, M.F., Kojima, M., Callicott, J.H., Goldberg, T.E., Kolachana, B.S., Bertolino, A., Zaitsev, E., Gold, B., Goldman, D., Dean, M., Lu, B., Weinberger, D.R., The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 112:2 (2003), 257–269.
23. Egger, M., Davey Smith, G., Schneider, M., Minder, C., Bias in meta-analysis detected by a simple, graphical test. BMJ 315:7109 (1997), 629–634.
24. Elfving, B., Plougmann, P.H., Muller, H.K., Mathe, A.A., Rosenberg, R., Wegener, G., Inverse correlation of brain and blood BDNF levels in a genetic rat model of depression. Int. J. Neuropsychopharmacol. 13:5 (2010), 563–572.
25. Eyre, H., Baune, B.T., Neuroimmunological effects of physical exercise in depression. Brain Behav. Immun. 26:2 (2012), 251–266.
26. Fang, Z., Lee, C., Seo, M., Cho, H., Lee, J., Lee, B., Park, S., Kim, Y., Effect of treadmill exercise on the BDNF-mediated pathway in the hippocampus of stressed rats. Neurosci. Res. 76:1–2 (2013), 187–194.
27. Ferrari, A.J., Somerville, A.J., Baxter, A.J., Norman, R., Patten, S.B., Vos, T., Whiteford, H.A., Global variation in the prevalence and incidence of major depressive disorder: a systematic review of the epidemiological literature. Psychol. Med. 43:3 (2013), 471–481.
28. Garza, A.A., Ha, T.G., Garcia, C., Chen, M.J., Russo-Neustadt, A.A., Exercise, antidepressant treatment, and BDNF mRNA expression in the aging brain. Pharmacol. Biochem. Behav. 77:2 (2004), 209–220.
29. Gleeson, M., Bishop, N.C., Stensel, D.J., Lindley, M.R., Mastana, S.S., Nimmo, M.A., The anti-inflammatory effects of exercise: mechanisms and implications for the prevention and treatment of disease. Nat. Rev. Immunol. 11:9 (2011), 607–615.
30. Gonul, A.S., Akdeniz, F., Taneli, F., Donat, O., Eker, C., Vahip, S., Effect of treatment on serum brain-derived neurotrophic factor levels in depressed patients. Eur. Arch. Psychiatr. Clin. Neurosci. 255:6 (2005), 381–386.
31. Gourgouvelis, J., Yielder, P., Clarke, S.T., Behbahani, H., Murphy, B.A., Exercise leads to better clinical outcomes in those receiving medication plus cognitive behavioral therapy for major depressive disorder. Front. Psychiatr., 9, 2018, 37.
32. Greenberg, P.E., Fournier, A.A., Sisitsky, T., Pike, C.T., Kessler, R.C., The economic burden of adults with major depressive disorder in the United States (2005 and 2010). J. Clin. Psychiatr. 76:2 (2015), 155–162.
33. Greenwood, B.N., Strong, P.V., Loughridge, A.B., Day, H.E., Clark, P.J., Mika, A., Hellwinkel, J.E., Spence, K.G., Fleshner, M., 5-HT2C receptors in the basolateral amygdala and dorsal striatum are a novel target for the anxiolytic and antidepressant effects of exercise. PLoS One, 7(9), 2012, e46118.
34. Gustafsson, G., Lira, C.M., Johansson, J., Wisen, A., Wohlfart, B., Ekman, R., Westrin, A., The acute response of plasma brain-derived neurotrophic factor as a result of exercise in major depressive disorder. Psychiatr. Res. 169:3 (2009), 244–248.
35. Harris, R.J., Bradburn, M.J., Deeks, J.J., Harbord, R.M., Altman, D.G., Sterne, J.A.C., metan: fixed- and random-effects meta-analysis. STATA J. 8:1 (2008), 3–28.
36. Haskell, W.L., Lee, I.M., Pate, R.R., Powell, K.E., Blair, S.N., Franklin, B.A., Macera, C.A., Heath, G.W., Thompson, P.D., Bauman, A., Physical activity and public health: updated recommendation for adults from the American College of Sports medicine and the American heart association. Med. Sci. Sports Exerc. 39:8 (2007), 1423–1434.
37. Herholz, K., Buskies, W., Rist, M., Pawlik, G., Hollmann, W., Heiss, W.D., Regional cerebral blood flow in man at rest and during exercise. J. Neurol. 234:1 (1987), 9–13.
38. Higgins, J.P., Thompson, S.G., Quantifying heterogeneity in a meta-analysis. Stat. Med. 21:11 (2002), 1539–1558.
39. Hofer, M., Pagliusi, S.R., Hohn, A., Leibrock, J., Barde, Y.A., Regional distribution of brain-derived neurotrophic factor mRNA in the adult mouse brain. EMBO J. 9:8 (1990), 2459–2464.
40. Hoshaw, B.A., Malberg, J.E., Lucki, I., Central administration of IGF-I and BDNF leads to long-lasting antidepressant-like effects. Brain Res. 1037:1–2 (2005), 204–208.
41. Kerling, A., Kuck, M., Tegtbur, U., Grams, L., Weber-Spickschen, S., Hanke, A., Stubbs, B., Kahl, K.G., Exercise increases serum brain-derived neurotrophic factor in patients with major depressive disorder. J. Affect. Disord. 215 (2017), 152–155.
42. Klein, A.B., Williamson, R., Santini, M.A., Clemmensen, C., Ettrup, A., Rios, M., Knudsen, G.M., Aznar, S., Blood BDNF concentrations reflect brain-tissue BDNF levels across species. Int. J. Neuropsychopharmacol. 14:3 (2011), 347–353.
43. Krogh, J., Rostrup, E., Thomsen, C., Elfving, B., Videbech, P., Nordentoft, M., The effect of exercise on hippocampal volume and neurotrophines in patients with major depression–a randomized clinical trial. J. Affect. Disord. 165 (2014), 24–30.
44. Laske, C., Banschbach, S., Stransky, E., Bosch, S., Straten, G., Machann, J., Fritsche, A., Hipp, A., Niess, A., Eschweiler, G.W., Exercise-induced normalization of decreased BDNF serum concentration in elderly women with remitted major depression. Int. J. Neuropsychopharmcol. 13:5 (2010), 595–602.
45. Lemos, J.R. Jr., Alves, C.R., de Souza, S.B., Marsiglia, J.D., Silva, M.S., Pereira, A.C., Teixeira, A.L., Vieira, E.L., Krieger, J.E., Negrao, C.E., Alves, G.B., de Oliveira, E.M., Bolani, W., Dias, R.G., Trombetta, I.C., Peripheral vascular reactivity and serum BDNF responses to aerobic training are impaired by the BDNF Val66Met polymorphism. Physiol. Genom. 48:2 (2016), 116–123.
46. Liu, Y.F., Chen, H.I., Wu, C.L., Kuo, Y.M., Yu, L., Huang, A.M., Wu, F.S., Chuang, J.I., Jen, C.J., Differential effects of treadmill running and wheel running on spatial or aversive learning and memory: roles of amygdalar brain-derived neurotrophic factor and synaptotagmin I. J. Physiol. (Lond.) 587:13 (2009), 3221–3231.
47. Liu, W., Sheng, H., Xu, Y., Liu, Y., Lu, J., Ni, X., Swimming exercise ameliorates depression-like behavior in chronically stressed rats: relevant to proinflammatory cytokines and Ido activation. Behav. Brain Res. 242 (2013), 110–116.
48. Lu, J., Xu, Y., Hu, W., Gao, Y., Ni, X., Sheng, H., Liu, Y., Exercise ameliorates depression-like behavior and increases hippocampal BDNF level in ovariectomized rats. Neurosci. Lett. 573 (2014), 13–18.
49. Marlatt, M.W., Potter, M.C., Lucassen, P.J., van Praag, H., Running throughout middle-age improves memory function, hippocampal neurogenesis, and BDNF levels in female C57BL/6J mice. Dev. Neurobiol. 72:6 (2012), 943–952.
50. Martinez-Turrillas, R., Del Rio, J., Frechilla, D., Sequential changes in BDNF mRNA expression and synaptic levels of AMPA receptor subunits in rat hippocampus after chronic antidepressant treatment. Neuropharmacology 49:8 (2005), 1178–1188.
51. Matrisciano, F., Bonaccorso, S., Ricciardi, A., Scaccianoce, S., Panaccione, I., Wang, L., Ruberto, A., Tatarelli, R., Nicoletti, F., Girardi, P., Shelton, R.C., Changes in BDNF serum levels in patients with major depression disorder (MDD) after 6 months treatment with sertraline, escitalopram, or venlafaxine. J. Psychiatr. Res. 43:3 (2009), 247–254.
52. Meyer, J.D., Ellingson, L.D., Koltyn, K.F., Stegner, A.J., Kim, J.S., Cook, D.B., Psychobiological responses to preferred and prescribed intensity exercise in major depressive disorder. Med. Sci. Sports Exerc. 48:11 (2016), 2207–2215.
53. Moher, D., Liberati, A., Tetzlaff, J., Altman, D.G., Group, P., Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ, 339, 2009, b2535.
54. Nabkasorn, C., Miyai, N., Sootmongkol, A., Junprasert, S., Yamamoto, H., Arita, M., Miyashita, K., Effects of physical exercise on depression, neuroendocrine stress hormones and physiological fitness in adolescent females with depressive symptoms. Eur. J. Publ. Health 16:2 (2006), 179–184.
55. Nibuya, M., Morinobu, S., Duman, R.S., Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J. Neurosci. : Official J. Soc. Neurosci. 15:11 (1995), 7539–7547.
56. Noble, J.E., Wang, L., Cerasoli, E., Knight, A.E., Porter, R.A., Gray, E., Howe, C., Hannes, E., Corbisier, P., Wang, J., Wu, L., Altieri, I., Patriarca, M., Hoffman, A., Resch-Genger, U., Ebert, B., Voigt, J., Shigeri, Y., Vonsky, M.S., Konopelko, L.A., Gaigalas, A.K., Bailey, M.J., An international comparability study to determine the sources of uncertainty associated with a non-competitive sandwich fluorescent ELISA. Clin. Chem. Lab. Med. 46:7 (2008), 1033–1045.
57. Numakawa, T., Suzuki, S., Kumamaru, E., Adachi, N., Richards, M., Kunugi, H., BDNF function and intracellular signaling in neurons. Histol. Histopathol. 25:2 (2010), 237–258.
58. Pan, W., Banks, W.A., Fasold, M.B., Bluth, J., Kastin, A.J., Transport of brain-derived neurotrophic factor across the blood-brain barrier. Neuropharmacology 37:12 (1998), 1553–1561.
59. Pareja-Galeano, H., Alis, R., Sanchis-Gomar, F., Cabo, H., Cortell-Ballester, J., Gomez-Cabrera, M.C., Lucia, A., Vina, J., Methodological considerations to determine the effect of exercise on brain-derived neurotrophic factor levels. Clin. Biochem. 48:3 (2015), 162–166.
60. Petryshen, T.L., Sabeti, P.C., Aldinger, K.A., Fry, B., Fan, J.B., Schaffner, S.F., Waggoner, S.G., Tahl, A.R., Sklar, P., Population genetic study of the brain-derived neurotrophic factor (BDNF) gene. Mol. Psychiatr. 15:8 (2010), 810–815.
61. Pillai, A., Kale, A., Joshi, S., Naphade, N., Raju, M.S., Nasrallah, H., Mahadik, S.P., Decreased BDNF levels in CSF of drug-naive first-episode psychotic subjects: correlation with plasma BDNF and psychopathology. Int. J. Neuropsychopharmacol. 13:4 (2010), 535–539.
62. Poduslo, J.F., Curran, G.L., Permeability at the blood-brain and blood-nerve barriers of the neurotrophic factors: NGF, CNTF, NT-3, BDNF. Brain Res. Mol. Brain Res. 36:2 (1996), 280–286.
63. Polyakova, M., Stuke, K., Schuemberg, K., Mueller, K., Schoenknecht, P., Schroeter, M.L., BDNF as a biomarker for successful treatment of mood disorders: a systematic & quantitative meta-analysis. J. Affect. Disord. 174 (2015), 432–440.
64. Reddy, M.S., Depression: the disorder and the burden. Indian J. Psychol. Med. 32:1 (2010), 1–2.
65. Rethorst, C.D., Toups, M.S., Greer, T.L., Nakonezny, P.A., Carmody, T.J., Grannemann, B.D., Huebinger, R.M., Barber, R.C., Trivedi, M.H., Pro-inflammatory cytokines as predictors of antidepressant effects of exercise in major depressive disorder. Mol. Psychiatr. 18:10 (2013), 1119–1124.
66. Salehi, I., Hosseini, S.M., Haghighi, M., Jahangard, L., Bajoghli, H., Gerber, M., Puhse, U., Holsboer-Trachsler, E., Brand, S., Electroconvulsive therapy (ECT) and aerobic exercise training (AET) increased plasma BDNF and ameliorated depressive symptoms in patients suffering from major depressive disorder. J. Psychiatr. Res. 76 (2016), 1–8.
67. Schmidt, H.D., Duman, R.S., Peripheral BDNF produces antidepressant-like effects in cellular and behavioral models. Neuropsychopharmacology 35:12 (2010), 2378–2391.
68. Schuch, F.B., Vasconcelos-Moreno, M.P., Borowsky, C., Zimmermann, A.B., Wollenhaupt-Aguiar, B., Ferrari, P., de Almeida Fleck, M.P., The effects of exercise on oxidative stress (TBARS) and BDNF in severely depressed inpatients. Eur. Arch. Psychiatr. Clin. Neurosci. 264:7 (2014), 605–613.
69. Schuch, F.B., Dunn, A.L., Kanitz, A.C., Delevatti, R.S., Fleck, M.P., Moderators of response in exercise treatment for depression: a systematic review. J. Affect. Disord. 195 (2016), 40–49.
70. Schuch, F.B., Vancampfort, D., Richards, J., Rosenbaum, S., Ward, P.B., Stubbs, B., Exercise as a treatment for depression: a meta-analysis adjusting for publication bias. J. Psychiatr. Res. 77 (2016), 42–51.
71. Siuciak, J.A., Lewis, D.R., Wiegand, S.J., Lindsay, R.M., Antidepressant-like effect of brain-derived neurotrophic factor (BDNF). Pharmacol. Biochem. Behav. 56:1 (1997), 131–137.
72. Thomas, A.G., Dennis, A., Bandettini, P.A., Johansen-Berg, H., The effects of aerobic activity on brain structure. Front. Psychol., 3, 2012, 86.
73. Toups, M.S., Greer, T.L., Kurian, B.T., Grannemann, B.D., Carmody, T.J., Huebinger, R., Rethorst, C., Trivedi, M.H., Effects of serum Brain Derived Neurotrophic Factor on exercise augmentation treatment of depression. J. Psychiatr. Res. 45:10 (2011), 1301–1306.
74. Trivedi, M.H., Greer, T.L., Church, T.S., Carmody, T.J., Grannemann, B.D., Galper, D.I., Dunn, A.L., Earnest, C.P., Sunderajan, P., Henley, S.S., Blair, S.N., Exercise as an augmentation treatment for nonremitted major depressive disorder: a randomized, parallel dose comparison. J. Clin. Psychiatr. 72:5 (2011), 677–684.
75. Ustun, T.B., Ayuso-Mateos, J.L., Chatterji, S., Mathers, C., Murray, C.J., Global burden of depressive disorders in the year 2000. Br. J. Psychiatry 184 (2004), 386–392.
76. Vinet, J., Carra, S., Blom, J.M., Brunello, N., Barden, N., Tascedda, F., Chronic treatment with desipramine and fluoxetine modulate BDNF, CaMKKalpha and CaMKKbeta mRNA levels in the hippocampus of transgenic mice expressing antisense RNA against the glucocorticoid receptor. Neuropharmacology 47:7 (2004), 1062–1069.
77. Zhang, D., Zhang, J., Ma, W., Chen, D., Han, H., Shu, H., Liu, G., Analysis of trace amino acid neurotransmitters in hypothalamus of rats after exhausting exercise using microdialysis. J. Chromatogr. B Biomed. Sci. Appl. 758:2 (2001), 277–282.
78. Zhang, Y., Gu, F., Chen, J., Dong, W., Chronic antidepressant administration alleviates frontal and hippocampal BDNF deficits in CUMS rat. Brain Res. 1366 (2010), 141–148.
79. Zhang, Q., Liu, G., Wu, Y., Sha, H., Zhang, P., Jia, J., BDNF promotes EGF-induced proliferation and migration of human fetal neural stem/progenitor cells via the PI3K/Akt pathway. Molecules 16:12 (2011), 10146–10156.